Fundraising Fox
/Companies
Sign in

Surgical Innovation Associates

Chicago, US · Delaware corporation · 2 known investors

Find your way into Surgical Innovation Associates

Each arrow is one introduction. Sign up to fill in the first one.

39 people can intro you to John

Ask Mary Guan to introduce you to John R Slump

You →Mary · together at Atraverse Medical →John

Sign up to find every way you can get introduced to Surgical Innovation Associates

  • Your email: who you already know at Surgical Innovation Associates, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Surgical Innovation Associates team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Commercializing improved resorbable surgical mesh as a safer and less expensive alternative for soft tissue support

Healthtech

Founders & leadership

AM
Alexei MlodinowFounder30 Under 30 2019
JO
Jason O'HearnChief Commercial Officer
JSJohn Slump
John SlumpChief Financial Officer2018–2022John Slump is Chief Financial Officer of Surgical Innovation Associates, which commercializes resorbable surgical mesh for soft tissue support. He has held executive roles at multiple medical device companies that were acquired by larger firms, including SIA (acquired by Integra), Attune Medical (acquired by Haemonetics), and Farapulse (acquired by Boston Scientific).
TC
Todd CruikshankExecutive
JY
John Y.S. Kim, M.D.Named on SEC filing

Board

RE
Ryan EgelandBoard director

Investors · 2

Harvard Business School Alumni Angels of Greater New Yorklisted by Harvard Business School Alumni Angels of Greater New YorkNew York

How we know: Harvard Business School Alumni Angels of Greater New York's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

$8.9M disclosed across 5 of 6 rounds · 2016–2022

▶$4.8MraisedApr 2021 · 59 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason O'HearnExecutive Officer
  • Ryan EgelandDirector
  • John Y.S. Kim, M.D.Director
  • Alexei MlodinowExecutive Officer, Director
  • John SlumpExecutive Officer
  • Todd CruikshankExecutive Officer
Amount sold
$4.8M
Minimum investment
$50K
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.7MraisedJun 2020 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John Y.S. Kim, M.D.Director
  • Ryan EgelandDirector
  • Alexei MlodinowExecutive Officer, Director
  • Todd CruikshankExecutive Officer
  • John SlumpExecutive Officer
Offering amount
$2M
Amount sold
$1.7M
Proceeds to insiders
$541.1K
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedApr 2019 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd CruikshankExecutive Officer
  • Alexei MlodinowExecutive Officer, Director
  • John Y.S. Kim, M.D.Director
Offering amount
$4M
Amount sold
$1.3M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$325KraisedMar 2018 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexei MlodinowExecutive Officer, Director
  • Todd CruikshankExecutive Officer
  • John Y.S. Kim, M.D.Director
Offering amount
$1.5M
Amount sold
$325K
Minimum investment
$10K
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$748KraisedJul 2017 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexei MlodinowExecutive Officer, Director
  • John Y.S. Kim, M.D.Director
  • Todd CruikshankExecutive Officer
Offering amount
$1.3M
Amount sold
$748K
Minimum investment
$10K
Proceeds to insiders
$60K
First sale
May 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Surgical Innovation Associates do?
Commercializing improved resorbable surgical mesh as a safer and less expensive alternative for soft tissue support
Who founded Surgical Innovation Associates?
Surgical Innovation Associates was founded by Alexei Mlodinow.
Who are Surgical Innovation Associates's investors?
Surgical Innovation Associates's investors include First Leaf Capital, Harvard Business School Alumni Angels of Greater New York.
How much funding has Surgical Innovation Associates raised?
Surgical Innovation Associates has disclosed $8.9M raised across 5 of its 6 known rounds.
Where is Surgical Innovation Associates headquartered?
Surgical Innovation Associates is headquartered in Chicago, US.